Department of Enzymology, Abilene Christian University, United States
Editorial
Targeting the Achilles Heel: Cancer Drug Targets for Precision Therapies
Author(s): Sumul Panday*
Cancer remains one of the most challenging and complex diseases
to combat, necessitating innovative therapeutic approaches that
specifically target vulnerabilities within cancer cells. This article delves
into the emerging landscape of cancer drug targets for precision
therapies, focusing on the concept of targeting the "Achilles' heel"
of cancer cells. Precision therapies aim to exploit unique molecular
aberrations and vulnerabilities present in cancer cells, while sparing
normal tissues, thereby enhancing treatment efficacy and minimizing
adverse effects. The identification and validation of cancer drug targets
require comprehensive genomic and proteomic analyses, uncovering
key driver mutations, altered signaling pathways, and dysregulated
cellular processes. Targeted therapies are designed to inhibit specific
oncogenic drivers, leading.. View More»